// App-Quantinova.ai

TPS1143 : SGN-LIV1A, an antibody-drug conjugate (ADC), in patients with LIV-1positive breast cancer.

Researchers

Presenter

  • Ana Kostic

Principal Investigators

  • Martha Anderson

  • Django Sussman

  • Steven Duniho

  • Jamie Miyamoto

  • Albina Nesterova

Medical Centers

  • Seattle Genetics, Bothell, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Peripheral neuropathy

  • Solid malignancies

Biomarkers

  • Human epidermal growth factor receptor 2

  • Solute Carrier Family 39 Member 6

  • Apparent diffusion coefficient

Drug/Treatment

  • SGN-LIV1A

Outcome

  • Unknown

Study Design

  • open label

  • pharmacokinetics

Phase

  • NA

Study Id's

  • NCT01969643

Sponsors

  • Seagen

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved